Bradly Wouters

Researcher
  • Princess Margaret Cancer Centre
  • University Health Network
  • University of Toronto
Home > About Us > Our People > Researcher Bio
  • Bio

Related Research

  • Multiple Cancers

    Triggers and Targets in the Tumour Microenvironment: Hypoxia and Beyond

    A leading team of scientists at Toronto’s Princess Margaret Cancer Centre is set to expand its groundbreaking research into the effects of low oxygen levels (hypoxia) on tumour aggressiveness th...

    Read More
  • Completed
    Multiple Cancers

    BC Cancer-Princess Margaret Pilot for the Marathon of Hope Cancer Centres

    In February of 2017, the Terry Fox Research Institute and two leading cancer centres in Canada – the Princess Margaret Cancer Centre in Toronto and BC Cancer in Vancouver –&...

    Read More
  • Completed
    Multiple Cancers

    Research pipeline for hypoxia-directed precision cancer medicine

    A new approach for a long-time funded Terry Fox research program has leaders of the initiative excited about personalizing treatment for cancer patients by bringing together two areas of study: genomi...

    Read More
  • Completed
    Multiple Cancers

    Hypoxia in tumours: clinical and experimental studies

    [Note: This project was funded before we started writing up individual stories for projects.] Scientific Summary  The overall hypothesis of our program is that the dynamic nature of the tumour mi...

    Read More

Related News & Events

  • TFRI News|May 26, 2021

    Le Réseau des centres d’oncologie du Marathon de l’espoir donne un coup d’accélérateur à son plan relatif à la médecine de précision en signant un accord de contribution avec Santé Canada

    Le gouvernement du Canada et l’Institut de recherche Terry Fox (IRTF) ont signé un accord de contribution qui pave la voie au Réseau des centres d’onc...

  • Press Release|May 26, 2021

    Marathon of Hope Cancer Centres Network accelerates precision medicine plan with signing of Contribution Agreement with Health Canada

    The Government of Canada and the Terry Fox Research Institute (TFRI) have jointly signed a Contribution Agreement which opens the door for the Maratho...

  • Research Highlight|September 01, 2020

    Developing precision medicine alternatives for triple negative breast cancer

    TFRI-funded scientists in Toronto have made a discovery that could unlock precision medicine treatments for patients diagnosed with triple negative br...

  • TFRI News|August 17, 2020

    Marathon of Hope Cancer Centres Network operational plan continues to take shape

    Plans for implementation of the new pan-Canadian network to accelerate precision medicine continue to move ahead with partners and leaders from the fo...

  • Press Release|July 11, 2019

    TFRI and partners react to investment of $150M by Federal Minister of Health to create “Team Canada of Cancer Research”

    The federal Minister of Health, Ginette Petitpas Taylor, announced today an investment of $150 million over five years by the Government of Canada for...

  • Press Release|July 03, 2019

    Trouver dans le microenvironnement des tumeurs de nouvelles cibles thérapeutiques en vue de personnaliser les traitements contre le cancer

    Une équipe de spécialistes chevronnés du Princess Margaret Cancer Centre de Toronto est appelée à élargir ses travaux de recherche novateurs sur les e...

  • Press Release|April 11, 2019

    Inspired by Terry Fox's legacy, Canadian cancer centres join forces for the first time

    Inspired by the legacy of Terry Fox, today the Terry Fox Research Institute and partners launched a new national network to bring together, for the fi...

  • Press Release|April 11, 2019

    Cancer centres and researchers in Atlantic Canada join forces to provide precision medicine for cancer patients across region

    For the first time, leading cancer centres, hospitals and researchers in Atlantic Canada are coming together to help deliver personalized and precisio...

  • Research Highlight|May 01, 2018

    Canadian leaders in tumour hypoxia shed light on the role of mTOR signalling in prostate cancer development

    More findings from TFRI’s prestigious hypoxia team are continuing to change the cancer research landscape when it comes to understanding the role of t...

  • All News & Events